✦ LIBER ✦

365 First-in-human, safety, pharmacodynamic (PD) and pharmacokinetic (PK) trial of a first-in-class dual RAF/MEK inhibitor, RO5126766, in patients with advanced or metastatic solid tumour

✍ Scribed by J.C. Soria; U. Banerji; R. Bahleda; M. Martinez Garcia; S. Dolly; L. Lee; R. Rueger; E. Guarin; V. Meresse; J. Albanell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic/pharmacodyna

✍ Kazunori Honda, Noboru Yamamoto, Hiroshi Nokihara… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 242 KB

374 Clinical, pharmacokinetic (PK) and p

✍ A. Awada; N. Houedé; J.P. Delord; M. Dubuisson; A. Italiano; Y. Bergé; S. Faivre 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

580 First-in-human, Safety, Pharmacokine

✍ Dienstmann, R.; Lassen, U.; Cebon, J.; Desai, J.; Brown, M.P.; Evers, S.; Su, F. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB